A proposed bill in South Carolina is stirring new controversy over the COVID-19 vaccine. If passed, the bill would require ...

Akeso has a validated process in place for developing antibodies but does require US exposure to meet its lofty valuation.

A proposed bill in South Carolina is stirring new controversy over the COVID-19 vaccine. If passed, the bill would require doctors and pharmacists to provide a ...

A UK study reveals COVID-19 poses greater long-term cardiac and clotting risks in children compared to minimal vaccine ...

As a damning report finds all four UK governments failed to appreciate the scale of the threat posed by COVID-19 or the ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

SC lawmakers advanced a bill that would require a disclaimer for COVID-19 vaccinations. Physicians have broadly encouraged ...

The German biopharmaceutical company BioNTech finds itself at a critical juncture following a significant divestment by its ...

Arturo Bris, IMD professor in geopolitics and business, examines Europe’s often-overlooked innovation engine, unpacking why ...

Strong clinical data doesn’t just move share prices – it can unlock lucrative global licensing deals for ASX-listed ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

The strategic partnership that yielded one of history's most successful vaccines reached a turning point this week. Pfizer ...